Rohan Palekar 89bio, Inc. (ETNB) insider trading activity

Rohan Palekar is Chief Executive Officer of 89bio, Inc.. Currently has a direct ownership of 808,070 shares of ETNB, which is worth approximately $11.9 Million. The most recent transaction as insider was on Mar 31, 2023, when has been sold 33,333 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 808K

6.28% 3M change

77.12% 12M change

Total Value Held $11.9 Million

ROHAN PALEKAR Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2023	BUY Grant, award, or other acquisition	-	33,333 Added 9.93%	302,413 Common Stock
Mar 23 2023	SELL Open market or private sale	$240,000 $16.0 p/Share	15,000 Reduced 5.28%	269,080 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$87,717 $13.97 p/Share	6,279 Reduced 2.16%	284,072 Common Stock
Feb 09 2023	BUY Grant, award, or other acquisition	-	75,000 Added 20.53%	290,351 Common Stock
Feb 05 2023	SELL Payment of exercise price or tax liability	$53,992 $13.24 p/Share	4,078 Reduced 1.86%	215,351 Common Stock
Sep 28 2022	SELL Payment of exercise price or tax liability	$66,396 $5.76 p/Share	11,527 Reduced 4.99%	219,429 Common Stock
Sep 28 2022	BUY Grant, award, or other acquisition	-	33,333 Added 12.61%	230,956 Common Stock
Sep 08 2022	BUY Exercise of conversion of derivative security	$193,000 $1.93 p/Share	100,000 Added 33.6%	197,623 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	54,200 Added 35.14%	100,045 Common Stock
Feb 05 2022	SELL Payment of exercise price or tax liability	$21,380 $5.23 p/Share	4,088 Reduced 4.09%	95,957 Common Stock
Jan 28 2022	BUY Open market or private purchase	$15,350 $6.14 p/Share	2,500 Added 5.17%	45,845 Common Stock
Jan 27 2022	BUY Open market or private purchase	$37,500 $7.5 p/Share	5,000 Added 10.34%	43,345 Common Stock
Jul 08 2021	BUY Open market or private purchase	$32,500 $16.25 p/Share	2,000 Added 5.13%	37,000 Common Stock
Jul 07 2021	BUY Open market or private purchase	$85,350 $17.07 p/Share	5,000 Added 12.5%	35,000 Common Stock
Feb 05 2021	BUY Grant, award, or other acquisition	-	30,000 Added 50.0%	30,000 Common Stock

Also insider at

NLTX

Neoleukin Therapeutics, Inc. Healthcare

Director

Rohan Palekar

Chief Executive Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETNB shares.

Notify only if

Value

Insider Trading

Get notified when an 89bio, Inc. insider buys or sells ETNB shares.

Notify only if

Operation

Value

Type

News

Receive news related to 89bio, Inc.

Track Activities on ETNB

Account